Related Experiment Videos

Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic

Roberto Maglie¹, Vieri Grandi¹, Emiliano Antiga¹

¹Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.

Journal of the American Academy of Dermatology

|September 2, 2019

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Upadacitinib for the Management of Atopic Dermatitis in Patients Aged ≥60 Years: A Long-Term Multicenter Real-World Study.

Dermatitis : contact, atopic, occupational, drug·2026

Efficacy and Safety of Delgocitinib and Its Impact on Patient's Perspective for Moderate-to-severe Chronic Hand Eczema in Adults: A 16-week Real-world Prospective Multicentre Study.

Acta dermato-venereologica·2026

Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes.

Journal of personalized medicine·2026

Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.

The British journal of dermatology·2026

GATA3-positivity and T follicular helper phenotype in transformed mycosis fungoides with leukemic involvement and prominent folliculotropism: a case report.

Frontiers in oncology·2026

Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.

Acta dermato-venereologica·2026

See all related articles